<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05097456</url>
  </required_header>
  <id_info>
    <org_study_id>0292-20-RMB</org_study_id>
    <nct_id>NCT05097456</nct_id>
  </id_info>
  <brief_title>Carbon Dioxide Acupulse Laser Treatment Versus Sham Treatment and Stress Urinary Incontinence Symptoms</brief_title>
  <official_title>Randomized, Double-blind, Sham-controlled Clinical Trial for Evaluating the Efficacy of Fractional Carbon Dioxide Laser in the Treatment of Stress Urinary Incontinence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rambam Health Care Campus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rambam Health Care Campus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is intended to assess the safety and efficacy of Carbon dioxide AcuPulse laser&#xD;
      treatment in patients with stress urinary incontinence. Eligible subjects will be randomized&#xD;
      to either receive 3 laser or 3 sham treatment sessions, 4 weeks apart and 3 follow up visits&#xD;
      3, 6 and 12 months following the last treatment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Following a screening visit, eligible subjects will be enrolled into the study. Subjects will&#xD;
      be randomized into either laser treatment or sham treatment. Each subject will receive 3&#xD;
      treatments 4 weeks apart and 3 follow up visits, at 3, 6 and 12 months following the last&#xD;
      treatment.&#xD;
&#xD;
      Further demographic information and patient history will be obtained from the subjects'&#xD;
      electronic files.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 1, 2022</start_date>
  <completion_date type="Anticipated">October 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pad weight test</measure>
    <time_frame>From treatment up to 12 months post treatment</time_frame>
    <description>Change in pad weight</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cough test</measure>
    <time_frame>From treatment up to 12 months post treatment</time_frame>
    <description>Positive cough test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary distress index questionnaire</measure>
    <time_frame>From treatment up to 12 months post treatment</time_frame>
    <description>Change in urinary distress index questionnaire scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>International consultation on incontinence questionnaire-urinary incontinence</measure>
    <time_frame>From treatment up to 12 months post treatment</time_frame>
    <description>Change in international consultation on incontinence questionnaire-urinary incontinence scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pelvic organ prolapse/urinary incontinence sexual questionnaire</measure>
    <time_frame>From treatment up to 12 months post treatment</time_frame>
    <description>Change in pelvic organ prolapse/urinary incontinence sexual questionnaire scores</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Stress Urinary Incontinence</condition>
  <arm_group>
    <arm_group_label>Laser treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>carbon dioxide treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham treatment</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>sham treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>carbon dioxide laser</intervention_name>
    <description>carbon dioxide laser</description>
    <arm_group_label>Laser treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham laser</intervention_name>
    <description>sham laser</description>
    <arm_group_label>Sham treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Negative urine analysis.&#xD;
&#xD;
          -  Normal Pap smear test from the recent 3 years.&#xD;
&#xD;
          -  No previous gynecological laser treatments.&#xD;
&#xD;
          -  Able and willing to comply with the treatment/follow-up schedule and requirements.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Active genital infection.&#xD;
&#xD;
          -  Subject presenting abnormal Pap result from the last three years.&#xD;
&#xD;
          -  Recurring urinary tract infection or recurring infection of genital herpes or candida&#xD;
             (&gt; 2 episodes in the recent year).&#xD;
&#xD;
          -  Transvaginal mesh implant.&#xD;
&#xD;
          -  Serious systemic disease or any chronic condition that could interfere with study&#xD;
             compliance.&#xD;
&#xD;
          -  Any vaginal bleeding of unknown reason.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Female patients</gender_description>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roy Lauterbach, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rambam healthcare campus</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Roy Lauterbach, MD</last_name>
    <phone>+972-52-9432416</phone>
    <email>r_lauterbach@rambam.health.gov.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rambam health care campus</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 4, 2021</study_first_submitted>
  <study_first_submitted_qc>October 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 28, 2021</study_first_posted>
  <last_update_submitted>October 19, 2021</last_update_submitted>
  <last_update_submitted_qc>October 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rambam Health Care Campus</investigator_affiliation>
    <investigator_full_name>ROY LAUTERBACH MD</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
    <mesh_term>Urinary Incontinence, Stress</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

